U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07684794) titled 'Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium - Maintenance' on June 22.
Brief Summary: The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif XCS System when used as indicated for treatment-resistant depression (TRD).
Study Start Date: Aug. 10
Study Type: INTERVENTIONAL
Condition:
Major Depressive Disorder (MDD)
Intervention:
DEVICE: Motif XCS System
The Motif XCS System is a programmable device that delivers stimulation through surface electrodes implanted in a burr hole in the skull, positioned over the left DLPFC, without penetrating the...